Cencora, Inc. (COR) has a MoatMap StockRank of 65/100 based on Quality (49/100), Value (36/100), and Momentum (63/100) factor scores. The current signal is BUY. Cencora, Inc. (formerly AmerisourceBergen), a major US pharmaceutical distributor, is a classic 'Moated Pricing Power & Quality' play. Its scale, network effects, and critical role in the healthcare supply chain create a formidable moat and consistent cash flows. The 'Resilient Supply Chain Build-out' theme further reinforces its value, as pharmaceutical distribution requires extreme reliability and security, which Cencora provides. In an environment of global supply chain re-architecture, the essential nature and logistical complexity of pharmaceutical distribution will command an even greater premium, which the market may not fully appreciate in its current valuation, presenting an asymmetric upside.